The utility of fFN for the prediction of preterm birth in twin gestations

R. Jeanne Ruiz, Judith Fullerton, Charles E L Brown

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objective: To determine the sensitivity, specificity, and positive predictive value (PPV) of fetal fibronectin (fFN) and to determine its usefulness, in conjunction with selected other clinical assessment measures, in the prediction of preterm birth for women with twin gestations. Design: A prospective, descriptive, longitudinal design. Setting: An obstetrical high-risk clinic that received patient referrals from several surrounding communities in central Texas. Patients/Participants: Forty-eight women identified with twin gestations prior to the 22nd week of pregnancy, primarily of Hispanic ethnicity. Main Outcome Measures: A substantial number of outcome variables were assessed in this study. In the present report, data derived from weekly assessments for the identification of the presence of fFN, the diagnosis of bacterial vaginosis, and the measurement of cervical length were reviewed for their relationship to prematurity, birth weight, birth weight discordancy and placental chorionicity. Results: The relative risk of birth prior to 35 weeks gestation, fetal death, or discordance of twin birth weights of greater than 20% was 2.22 (CI: 1.09, 4.55, P < 0.015) when fFN was found to be positive at any weekly testing after 22 to 24 weeks gestation (sensitivity 76.82%, specificity 58.33%, PPV 66.7%). The presence of fFN was most highly predictive of preterm birth when performed during the 24th to 28th gestational week. Shorter cervical lengths were highly correlated with preterm birth (r = -0.6). An association between bacterial vaginosis and preterm birth was not demonstrated in this sample. Conclusion: Sampling for the presence of fetal fibronectin can be easily accomplished by RNs in labor triage units and by advanced practice nurses in outpatient settings. The identification of fFN, particularly during the 24 to 28 weeks gestational time frame, is highly predictive of preterm birth, and particularly so for women with twin gestations.

Original languageEnglish (US)
Pages (from-to)446-454
Number of pages9
JournalJOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing
Volume33
Issue number4
DOIs
StatePublished - Jul 2004

Fingerprint

Premature Birth
Fibronectins
Pregnancy
Birth Weight
Bacterial Vaginosis
Cervical Length Measurement
Sensitivity and Specificity
Fetal Death
Triage
Hispanic Americans
Outpatients
Referral and Consultation
Nurses
Outcome Assessment (Health Care)
Parturition

Keywords

  • Fetal fibronectin
  • Preterm birth
  • Twin gestation

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Pediatrics, Perinatology, and Child Health
  • Medicine(all)

Cite this

The utility of fFN for the prediction of preterm birth in twin gestations. / Ruiz, R. Jeanne; Fullerton, Judith; Brown, Charles E L.

In: JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing, Vol. 33, No. 4, 07.2004, p. 446-454.

Research output: Contribution to journalArticle

Ruiz, R. Jeanne ; Fullerton, Judith ; Brown, Charles E L. / The utility of fFN for the prediction of preterm birth in twin gestations. In: JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing. 2004 ; Vol. 33, No. 4. pp. 446-454.
@article{29fbe8e831a4457581f8539efd34b485,
title = "The utility of fFN for the prediction of preterm birth in twin gestations",
abstract = "Objective: To determine the sensitivity, specificity, and positive predictive value (PPV) of fetal fibronectin (fFN) and to determine its usefulness, in conjunction with selected other clinical assessment measures, in the prediction of preterm birth for women with twin gestations. Design: A prospective, descriptive, longitudinal design. Setting: An obstetrical high-risk clinic that received patient referrals from several surrounding communities in central Texas. Patients/Participants: Forty-eight women identified with twin gestations prior to the 22nd week of pregnancy, primarily of Hispanic ethnicity. Main Outcome Measures: A substantial number of outcome variables were assessed in this study. In the present report, data derived from weekly assessments for the identification of the presence of fFN, the diagnosis of bacterial vaginosis, and the measurement of cervical length were reviewed for their relationship to prematurity, birth weight, birth weight discordancy and placental chorionicity. Results: The relative risk of birth prior to 35 weeks gestation, fetal death, or discordance of twin birth weights of greater than 20{\%} was 2.22 (CI: 1.09, 4.55, P < 0.015) when fFN was found to be positive at any weekly testing after 22 to 24 weeks gestation (sensitivity 76.82{\%}, specificity 58.33{\%}, PPV 66.7{\%}). The presence of fFN was most highly predictive of preterm birth when performed during the 24th to 28th gestational week. Shorter cervical lengths were highly correlated with preterm birth (r = -0.6). An association between bacterial vaginosis and preterm birth was not demonstrated in this sample. Conclusion: Sampling for the presence of fetal fibronectin can be easily accomplished by RNs in labor triage units and by advanced practice nurses in outpatient settings. The identification of fFN, particularly during the 24 to 28 weeks gestational time frame, is highly predictive of preterm birth, and particularly so for women with twin gestations.",
keywords = "Fetal fibronectin, Preterm birth, Twin gestation",
author = "Ruiz, {R. Jeanne} and Judith Fullerton and Brown, {Charles E L}",
year = "2004",
month = "7",
doi = "10.1177/0884217504267270",
language = "English (US)",
volume = "33",
pages = "446--454",
journal = "JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing",
issn = "0884-2175",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - The utility of fFN for the prediction of preterm birth in twin gestations

AU - Ruiz, R. Jeanne

AU - Fullerton, Judith

AU - Brown, Charles E L

PY - 2004/7

Y1 - 2004/7

N2 - Objective: To determine the sensitivity, specificity, and positive predictive value (PPV) of fetal fibronectin (fFN) and to determine its usefulness, in conjunction with selected other clinical assessment measures, in the prediction of preterm birth for women with twin gestations. Design: A prospective, descriptive, longitudinal design. Setting: An obstetrical high-risk clinic that received patient referrals from several surrounding communities in central Texas. Patients/Participants: Forty-eight women identified with twin gestations prior to the 22nd week of pregnancy, primarily of Hispanic ethnicity. Main Outcome Measures: A substantial number of outcome variables were assessed in this study. In the present report, data derived from weekly assessments for the identification of the presence of fFN, the diagnosis of bacterial vaginosis, and the measurement of cervical length were reviewed for their relationship to prematurity, birth weight, birth weight discordancy and placental chorionicity. Results: The relative risk of birth prior to 35 weeks gestation, fetal death, or discordance of twin birth weights of greater than 20% was 2.22 (CI: 1.09, 4.55, P < 0.015) when fFN was found to be positive at any weekly testing after 22 to 24 weeks gestation (sensitivity 76.82%, specificity 58.33%, PPV 66.7%). The presence of fFN was most highly predictive of preterm birth when performed during the 24th to 28th gestational week. Shorter cervical lengths were highly correlated with preterm birth (r = -0.6). An association between bacterial vaginosis and preterm birth was not demonstrated in this sample. Conclusion: Sampling for the presence of fetal fibronectin can be easily accomplished by RNs in labor triage units and by advanced practice nurses in outpatient settings. The identification of fFN, particularly during the 24 to 28 weeks gestational time frame, is highly predictive of preterm birth, and particularly so for women with twin gestations.

AB - Objective: To determine the sensitivity, specificity, and positive predictive value (PPV) of fetal fibronectin (fFN) and to determine its usefulness, in conjunction with selected other clinical assessment measures, in the prediction of preterm birth for women with twin gestations. Design: A prospective, descriptive, longitudinal design. Setting: An obstetrical high-risk clinic that received patient referrals from several surrounding communities in central Texas. Patients/Participants: Forty-eight women identified with twin gestations prior to the 22nd week of pregnancy, primarily of Hispanic ethnicity. Main Outcome Measures: A substantial number of outcome variables were assessed in this study. In the present report, data derived from weekly assessments for the identification of the presence of fFN, the diagnosis of bacterial vaginosis, and the measurement of cervical length were reviewed for their relationship to prematurity, birth weight, birth weight discordancy and placental chorionicity. Results: The relative risk of birth prior to 35 weeks gestation, fetal death, or discordance of twin birth weights of greater than 20% was 2.22 (CI: 1.09, 4.55, P < 0.015) when fFN was found to be positive at any weekly testing after 22 to 24 weeks gestation (sensitivity 76.82%, specificity 58.33%, PPV 66.7%). The presence of fFN was most highly predictive of preterm birth when performed during the 24th to 28th gestational week. Shorter cervical lengths were highly correlated with preterm birth (r = -0.6). An association between bacterial vaginosis and preterm birth was not demonstrated in this sample. Conclusion: Sampling for the presence of fetal fibronectin can be easily accomplished by RNs in labor triage units and by advanced practice nurses in outpatient settings. The identification of fFN, particularly during the 24 to 28 weeks gestational time frame, is highly predictive of preterm birth, and particularly so for women with twin gestations.

KW - Fetal fibronectin

KW - Preterm birth

KW - Twin gestation

UR - http://www.scopus.com/inward/record.url?scp=4644274267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644274267&partnerID=8YFLogxK

U2 - 10.1177/0884217504267270

DO - 10.1177/0884217504267270

M3 - Article

VL - 33

SP - 446

EP - 454

JO - JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing

JF - JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing

SN - 0884-2175

IS - 4

ER -